Montelukast Intermediate Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Montelukast Intermediate Market is anticipated to grow at a significant CAGR during the forecast period. The major factors responsible for the growth of the market during the forecast period include an increase in demand for the montelukast intermediate from API (Active Pharmaceutical Ingredient) manufacturers, an increase in presence of generics as well as rising prevalence of asthma, bronchospasm, allergic rhinitis, and urticaria.
The montelukast intermediates are
used to prevent wheezing, difficulty in breathing, chest tightness, and
coughing caused by asthma. Moreover, montelukast is designated for the handling
of periodic and recurrent allergic rhinitis. The important aspects pouring the
market’s evolution include globally rising commonness of allergic rhinitis,
urticaria, asthma, bronchospasm, burgeoning pharmaceutical industry attached
with the rising call from active pharmaceutical ingredients (APIs)
manufacturers, and montelukast patent expiration.
The global montelukast intermediate market analysis
includes some of the key market players such as Aurobindo Pharma Ltd., Glenmark
Pharmaceuticals Ltd., and Merck & Co., Inc., among others. To maintain a
strong position in the market, the market players are adopting various
strategic moves, such as product launches, partnerships, collaborations, and
mergers and acquisitions. For instance, in November 2020, Mylan received
clearance from the US Federal Trade Commission (FTC) to advance the merger of
Pfizer's Upjohn generics unit.
To Request a Sample of our Report on Montelukast
Intermediate Market: https://www.omrglobal.com/request-sample/montelukast-intermediate-market
Market Coverage
·
The market number available for – 2022-2030
·
Base year- 2022
·
Forecast period- 2022-2030
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Aurobindo Pharma Ltd.,
Glenmark Pharmaceuticals Ltd., and Merck & Co., Inc., among others.
Montelukast Intermediate Market Report by Segment
By Application
• Asthma
• Allergic Rhinitis
• Bronchospasm
• Urticaria
A
full Report of Montelukast Intermediate Market is Available at: https://www.omrglobal.com/industry-reports/montelukast-intermediate-market
Montelukast Intermediate Market by Regional Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research
and consulting company known for its crisp and concise reports. The company is
equipped with an experienced team of analysts and consultants. OMR offers
quality syndicated research reports, customized research reports, consulting
and other research-based services. The company also offer Digital Marketing
services through its subsidiary OMR Digital and Software development and Consulting Services through another
subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment